Arvinas and Pfizer Enter into a Transaction with Rigel Pharmaceuticals for the Exclusive Global Rights of VEPPANU (vepdegestrant)
Go back to Arvinas and Pfizer Enter into a Transaction with Rigel Pharmaceuticals for the Exclusive Global Rights of VEPPANU (vepdegestrant)| (NASDAQ: ARVN) | Delayed: 7.67 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $7.67 | 52 Week High | $ | |||
| Open | $7.67 | 52 Week Low | $ | |||
| Day High | $7.67 | P/E | N/A | |||
| Day Low | $7.67 | EPS | $ | |||
| Volume | 4,108 | |||||
| (NASDAQ: ARVN) | Delayed: 7.67 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $7.67 | 52 Week High | $ | |||
| Open | $7.67 | 52 Week Low | $ | |||
| Day High | $7.67 | P/E | N/A | |||
| Day Low | $7.67 | EPS | $ | |||
| Volume | 4,108 | |||||
| Pfizer Inc. (NYSE: PFE) | Delayed: 25.21 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $25.21 | 52 Week High | $37.39 | |||
| Open | $25.21 | 52 Week Low | $28.25 | |||
| Day High | $25.21 | P/E | 15.28 | |||
| Day Low | $25.21 | EPS | $1.65 | |||
| Volume | 104,289 | |||||

